Boceprevir Advisory Committee

First Page		Document Content
Protease inhibitors Pharmacology Biology Hepatitis Boceprevir Cytokines Hepatitis C and HIV co-infection Hepatitis C virus Peginterferon alfa-2a Antivirals HIV/AIDS Medicine		Boceprevir Advisory Committee Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 380,17 KB Share Document on Facebook

	Contact PD/PI: Braithwaite, Ronald Scott A. SPECIFIC AIMS Many persons with HIV have Hepatitis C (HCV) co-infection and consume alcohol.1,2 Now that highly effective and easily tolerated therapies for HCV are available, DocID: 1vbzY - View Document
	2013 Hepatitis C Medicines and Diagnostics in the Context of HIV/HCV Co-Infection: A Scoping Report october 2013 DocID: 1nVRo - View Document
	EDITORIAL Eradication of Hepatitis C Infection: The Importance of Targeting People Who Inject Drugs H DocID: 1gyH4 - View Document
	Back to old version Get access Journal of Viral Hepatitis Early View Online Version of Record published before inclusion in an issue DocID: 1guAK - View Document
	Journal of Viral Hepatitis, 2007, 14, 413–418 doi:j00812.x High incidence of hepatitis C virus reinfection within a cohort of injecting drug users DocID: 1gsv4 - View Document